Enterprise record
Alpha ID: alpha:company:b4b36520-180e-4a7b-ac27-14a6ef7429c7Version: public-1
28 published Claims6 sources
The enterprise, in context.
Connect capital, control, accountability, and evidence.
Governance priorities
Capital allocationInspect reported performance, cash generation, and investment.Board accountabilityWho holds each mandate, and what evidence supports it?Ownership & votingSeparate economic interests from voting authority.Key Claims
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 3, 2026
Supports 3 claims
- Legal Name: Oruka Therapeutics, Inc. · Claim reviewed: Oct 3, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 3, 2026
- Published Fact: US · Claim reviewed: Oct 3, 2026
SEC DEF 14A 0001213900-26-045159
sec def 14a · Source published: Apr 17, 2026 · Retrieved: Sep 12, 2026
Supports 7 claims
- Leadership Role: Samarth Kulkarni: Director and Chair · Claim reviewed: Oct 3, 2026
- Leadership Role: Lawrence Klein: Chief Executive Officer and Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Arjun Agarwal: Senior Vice President, Finance and Treasurer · Claim reviewed: Oct 3, 2026
- Leadership Role: Joana Goncalves: Chief Medical Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Laura Sandler: Chief Operating Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Lawrence Klein: President and Chief Executive Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Paul Quinlan: General Counsel and Corporate Secretary · Claim reviewed: Oct 3, 2026
DEF 14A ea0286400-01.htm
sec proxy · Source published: Apr 17, 2026 · Retrieved: Sep 2, 2026
Supports 6 claims
- Leadership Role: Cameron Turtle: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Carl Dambkowski: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Chris Martin: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Kristine Ball: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Paul Quinlan: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Peter Harwin: Director · Claim reviewed: Oct 3, 2026
Audit Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 5 claims
- Committee Record: Audit Committee: Chair Kristine Ball; Members Kristine Ball (Chair); Cameron Turtle; Carl Dambkowski; Chris Martin · Claim reviewed: Oct 3, 2026
- Committee Appointment: Kristine Ball: chair, Audit Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Cameron Turtle: member, Audit Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Carl Dambkowski: member, Audit Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Chris Martin: member, Audit Committee · Claim reviewed: Oct 3, 2026
Compensation Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 4 claims
- Committee Record: Compensation Committee: Chair Chris Martin; Members Chris Martin (Chair); Cameron Turtle; Peter Harwin · Claim reviewed: Oct 3, 2026
- Committee Appointment: Chris Martin: chair, Compensation Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Cameron Turtle: member, Compensation Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Peter Harwin: member, Compensation Committee · Claim reviewed: Oct 3, 2026
Nominating and Corporate Governance Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 3 claims
- Committee Record: Nominating and Corporate Governance Committee: Chair Peter Harwin; Members Peter Harwin (Chair); Kristine Ball · Claim reviewed: Oct 3, 2026
- Committee Appointment: Peter Harwin: chair, Nominating and Corporate Governance Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Kristine Ball: member, Nominating and Corporate Governance Committee · Claim reviewed: Oct 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed